Low-vision Rehabilitation Program for Low-vision Patients and Care Givers

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Unknown status
CT.gov ID
NCT03166072
Collaborator
(none)
150
1
2
15
10

Study Details

Study Description

Brief Summary

To evaluate health related quality of life (HRQoL) of low-vision patients and their care givers undergoing low-vision rehabilitation program (LVRP).

Condition or Disease Intervention/Treatment Phase
  • Other: Low-vision rehabilitation program
  • Other: No Intervention
N/A

Detailed Description

To conduct a pilot single-center, single blind longitudinal randomized controlled trial to evaluate health related quality of life (HRQoL) of low-vision patients and their care givers undergoing low-vision rehabilitation program (LVRP). LVRP includes functional vision assessments (low-vision refraction), prescription of a variety of visual aids including microscopes, magnifiers, telescopes, absorptive filters and electronic spectacle eyewear, large print books, and automatic self-transcending meditation plus essential skills for daily living and mobility training offered by Canadian National Institute for the Blind (CNIB) including demonstration of visual aids as well as training on proper use of visual aids.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Low-vision Rehabilitation Program for Low-vision Patients and Care Givers: A Single Blind Longitudinal Randomized Controlled Trial
Anticipated Study Start Date :
Sep 1, 2018
Anticipated Primary Completion Date :
Jul 1, 2019
Anticipated Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Low-vision rehabilitation program

Participants and their care givers in Low-vision rehabilitation program will undergo a standardized interview to measure HRQoL using the time trade-off method (TTO), depression using the Patient Health Questionnaire (PHQ-9), anxiety using Generalized Anxiety Disorder (GAD-7) and Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48) at the first study visit and after Low-vision rehabilitation program.

Other: Low-vision rehabilitation program
Low Vision Rehabilitation Program includes functional vision assessments (low-vision refraction), prescription of a variety of visual aids including microscopes, magnifiers, telescopes, absorptive filters and electronic spectacle eyewear, large print books, and automatic self-transcending meditation plus essential skills for daily living and mobility training offered by CNIB including demonstration of visual aids as well as training on proper use of visual aids.

Placebo Comparator: No Intervention

Participants and their care givers will undergo a standardized interview to measure HRQoL using the time trade-off method (TTO), depression using the Patient Health Questionnaire (PHQ-9), anxiety using Generalized Anxiety Disorder (GAD-7) and Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48) at the first study visit and will continue to receive treatment as usual.

Other: No Intervention
Participants will continue to receive treatment as usual

Outcome Measures

Primary Outcome Measures

  1. Change in Health related Quality of Life (HRQoL) [Change from baseline up to 24 weeks]

    HRQoL is measured using time trade-off (TTO) method

Secondary Outcome Measures

  1. Change in Depression Score [Change from baseline up to 24 weeks]

    Depression measured using the Patient Health Questionnaire (PHQ-9)

  2. Change in Anxiety Score [Change from baseline up to 24 weeks]

    Anxiety measured using the Generalized Anxiety Disorder (GAD-7)

  3. Change in Low vision Score [Change from baseline up to 24 weeks]

    Low visual function measured using the Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48)

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • at least 50 years of age

  • has low-vision,

  • deemed competent such as no language issues or communication barriers, no self-reported or physician diagnosed mental health disorder besides having depressive and anxiety symptoms,

  • have sufficient hearing to be able to follow verbal instructions and able to sit without physical discomfort for 30 minutes

  • willing and able to attend 4 initial ASTM training sessions and at least 75% of weekly, bi-weekly and monthly follow up sessions,

  • willing to dedicate 20 minutes twice per day to ASTM practice at their own home.

Exclusion Criteria:
  • actively suicidal as per self-report (scoring 2 or more on item 9 of the Patient Health Questionnaire (PHQ-9) or on assessment by the physician,

  • currently participating in other similar studies

  • currently practicing any type of formal meditation regularly

Contacts and Locations

Locations

Site City State Country Postal Code
1 St. Joseph's Hospital, Ivey Eye Institute London Ontario Canada N6G0H8

Sponsors and Collaborators

  • Lawson Health Research Institute

Investigators

  • Principal Investigator: Monali Malvankar, University of Western Ontario, Canada

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Monali Malvankar, Assistant Professor, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT03166072
Other Study ID Numbers:
  • 10016927
First Posted:
May 24, 2017
Last Update Posted:
Aug 24, 2017
Last Verified:
Aug 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Monali Malvankar, Assistant Professor, Lawson Health Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2017